Humoral Immunity to AAV-6, 8, and 9 in Normal and Dystrophic Dogs
- 1 March 2012
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 23 (3), 287-294
- https://doi.org/10.1089/hum.2011.125
Abstract
Adeno-associated virus (AAV)-6, 8, and 9 are promising gene-delivery vectors for testing novel Duchenne muscular dystrophy gene therapy in the canine model. Humoral immunity greatly influences in vivo AAV transduction. However, neutralizing antibodies to AAV-6, 8, and 9 have not been systemically examined in normal and dystrophic dogs. To gain information on the seroprevalence of antibodies to AAV-6, 8, and 9, we measured neutralizing antibody titers using an in vitro transduction inhibition assay. We examined 72 naive serum samples and 26 serum samples obtained from dogs that had received AAV gene transfer. Our data demonstrated that AAV-6 neutralizing antibody was the most prevalent antibody in dogs irrespective of age, gender, disease status (dystrophic or not), and prior parvovirus vaccination history. Surprisingly, high-level anti-AAV-6 antibody was detected at birth in newborn puppies. Further, a robust antibody response was induced in affected, but not normal newborn dogs following systemic AAV gene transfer. Taken together, our data have provided an important baseline on the seroprevalence of AAV-6, 8, and 9 neutralizing antibodies in normal and Duchenne muscular dystrophy dogs. These results will help guide translational AAV gene-therapy studies in dog models of muscular dystrophy.Keywords
This publication has 51 references indexed in Scilit:
- Neutralizing Antibodies Against AAV Serotypes 1, 2, 6, and 9 in Sera of Commonly Used Animal ModelsMolecular Therapy, 2012
- Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogsNeuromuscular Disorders, 2011
- Whole Body Skeletal Muscle Transduction in Neonatal Dogs with AAV-9Methods in molecular biology (Clifton, N.J.), 2010
- Preexisting Immunity and Low Expression in Primates Highlight Translational Challenges for Liver-directed AAV8-mediated Gene TherapyMolecular Therapy, 2010
- An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breedLaboratory Investigation, 2010
- The Pleiotropic Effects of Natural AAV Infections on Liver-directed Gene Transfer in MacaquesMolecular Therapy, 2010
- Evaluation of Vascular Delivery Methodologies to Enhance rAAV6-mediated Gene Transfer to Canine Striated MusculatureMolecular Therapy, 2009
- Transduction Efficiency and Immune Response Associated With the Administration of AAV8 Vector Into Dog Skeletal MuscleMolecular Therapy, 2009
- A Single Intravenous Injection of Adeno-associated Virus Serotype-9 Leads to Whole Body Skeletal Muscle Transduction in DogsMolecular Therapy, 2008
- Efficient Whole-body Transduction with Trans-splicing Adeno-associated Viral VectorsMolecular Therapy, 2007